Literature DB >> 25694760

Observation of short-term catheter induced thrombosis in children treated with blood purification.

S Li1, Xm Sun1, Z Wang1.   

Abstract

BACKGROUND: No studies have assessed the safety of short-term catheter-induced thrombosis in children treated with blood purification. The aim of this study was to determine the incidence and evolution of thrombosis in the children.
METHODS: One hundred nineteen (119) children treated with blood purification were enrolled. The data of baseline characteristics, coagulation status and type of catheters were recorded. Thrombosis- related symptoms and signs, ultrasound examinations of the right femoral veins were followed for 2 months. The relationship between associated risk factors (age, sex and type of catheters) and thrombosis was analyzed.
RESULTS: Of the 119 patients, 95 (79.8%) developed deep venous thrombosis (DVT) in the right external iliac veins. In only one patient it was clinically obvious. The incidence of thrombosis had no significant difference between the following subgroups: 1. Children under 6 years (14/15, 93.3%), 6-12 years (63/78, 80.7%) and above 12 years (18/26, 69.2%) (p=0.436); 2. Male (57/66, 86.3%) and female patients (38/53, 71.6%) (p=0.448); 3. Children catheterized with 8F (52/63, 82.5%) and 11F catheters (43/56, 76.7%) (p=0.435). Thrombolysis was achieved in 77 cases (77/80, 96.3%) with treatment of oral dipyridamole at one month and 80 cases (100%) at two months.
CONCLUSION: Children treated with blood purification through short-term femoral venous catheters have an increased risk of developing DVT, which is usually asymptomatic and good in prognosis. Hippokratia 2014; 18 (3): 245-250.

Entities:  

Keywords:  Deep venous thrombosis; blood purification; children; femoral venous catheters; hemoperfusion

Year:  2014        PMID: 25694760      PMCID: PMC4309146     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  9 in total

1.  Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients.

Authors:  G M Joynt; J Kew; C D Gomersall; V Y Leung; E K Liu
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

Review 2.  2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group.

Authors:  P Debourdeau; D Kassab Chahmi; G Le Gal; I Kriegel; E Desruennes; M-C Douard; I Elalamy; G Meyer; P Mismetti; M Pavic; M-L Scrobohaci; H Lévesque; J M Renaudin; D Farge
Journal:  Ann Oncol       Date:  2009-06-12       Impact factor: 32.976

3.  The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura.

Authors:  J A Mills; B A Michel; D A Bloch; L H Calabrese; G G Hunder; W P Arend; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

4.  Tinzaparin is safe and effective in the management of hemodialysis catheter thrombosis.

Authors:  Catherine Quinlan; Marie Bates; Melanie Cotter; Michael Riordan; Mary Waldron; Atif Awan
Journal:  ASAIO J       Date:  2012 May-Jun       Impact factor: 2.872

5.  Catheter-related deep venous thrombosis and other catheter complications in children with cancer.

Authors:  Janna M Journeycake; George R Buchanan
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

6.  Significant association with location of central venous line placement and risk of venous thrombosis in children.

Authors:  Christoph Male; Jim A Julian; Patricia Massicotte; Michael Gent; Lesley Mitchell
Journal:  Thromb Haemost       Date:  2005-09       Impact factor: 5.249

7.  A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children.

Authors:  Neil A Goldenberg; Janette D Durham; R Knapp-Clevenger; Marilyn J Manco-Johnson
Journal:  Blood       Date:  2007-03-14       Impact factor: 22.113

8.  Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis.

Authors:  Lina Chen; Zheng Wang; Songhui Zhai; Hui Zhang; Jing Lu; Xiuying Chen
Journal:  Int J Artif Organs       Date:  2013-05-10       Impact factor: 1.595

Review 9.  Henoch-Schönlein purpura in children.

Authors:  Peter Trnka
Journal:  J Paediatr Child Health       Date:  2013-10-18       Impact factor: 1.954

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.